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It is known that penicillin as produced in culture by strains of PenicilUum 
notatum or chrysogenum  consists of at least four distinct molecular species (1), 
and there is reason to suspect that additional peniclnlns may be present, not 
as yet chemically identified.  There is the further possibility that by adding 
appropriate precursor substances to the nutrient medium, the mold may be 
induced to  synthesize penicillins not formed on  the  media ordinarily used; 
and a  large number of penicillin derivatives, biologically active, have been 
formed by appropriate chemical treatment of the natural product. 
The question has of course arisen as to whether these penicillins differ signifi- 
cantly in  their bactericidal activity in  vitro  and  therapeutic  action in  vivo. 
There is already affirmative evidence on both these points.  The four "natural" 
penicillins have been shown to vary widely in their in vitro activity against 
staphylococci (1), streptococci (2), and spirochetes (2).  Further, penicillin X 
has been found to  be  several times more  active than commercial penicillin 
against streptococci, gonococci, meningococci, and pneumococci in vitro (3, 4), 
and more effective than G also in the treatment of gonorrhea in man (3). 
The present paper will describe the relative activities of penicillins F, G, K, 
and X  in the treatment of experimental infections with Streptococcus pyogenes 
and Pneumococcus Type I.  The significant differences observed suggest the 
desirability of using  specific  types  of peniciUins  against  specific  infections. 
Apparent discrepancies between the relative bactericidal action of the several 
penicillins in  vitro  and their therapeutic efficacy against the same organism 
in vivo have been shown to be related to the widely varying blood levels ob- 
tained when these penicillins are administered in equal dosage. 
Methods and Materials 
PenicilUns.--The crystalline  penieillins  used in these studies were generously  provided  by 
the following  companies: 
F--The Upjohn Company--Lot 175EANW6; G--E.  R.  Squibb and Sons---Lot CRA- 
214-20; K--Abbott Laboratories--Lot RP309P2 and 509A030; Charles Pfizer  and Co., Inc.-- 
Lot (5-2-46); X--Lederle Laboratories~ Inc.--Lot CA3242-IC. 
Because penicillin  K was not at the time  available  in adequate amounts, in some of the ex- 
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periments a preparation was used (Abbott 506A030) containing  approximately 65 per cent of 
inert material, but in which penicillin K was said to constitute more than 90 per cent of the 
contained penicillin as determined by chromatographic adsorption (13). 
Baaerial Infections.--Mice  weighing 18 to 22 gin., averaging 20 gin., were inoculated intra- 
peritoneally with 0.2 cc. of diluted 18 to 24 hour blood-broth cultures of Streptococcus pyog~4es 
(strain  C-203)  or Pneumococcus Type I.  The exact dilutions used as  ifloculum and  the 
minimum  lethal dose represented by those dilutions are given in the tables. 
Treatment with Penieillin.--Treatment with penicillin  was begun 2 hours after inoculation, 
and was repeated every 3 hours to a total of ten injections.  The dosages were varied serially 
twofold, using similarly varying concentrations in a fixed volume of 0.2 cc. per injection.  Al- 
though the penicillin solutions were injected into the muscles of the hind leg, there was con- 
siderable leakage into the soft tissues, and the treatment should be considered a combination  of 
intramuscular  and subcutaneous  administration. 
Obser~ation.--Mice were observed for 7 to  14 days before being adjudged cured.  Control 
animals died regularly in 24 to 48 hours; and the majority of the treatment failures had died 
within 3 to 5 days after the last injection of penicillin. 
In Vitro Assays of Bactericidal Activity of Penicillins.--The method used for the assay of 
streptococcidal activity has been described in detail elsewhere (2, 5). 
The method used for the assay of pneumococcidal activity was a  combination of turbidi- 
metric and colorimetric, using 0.1 per cent dextrose-broth with an internal indicator (brom 
cresol  purple in 0.003  per cent concentration).  The medium was further enriched by the 
addition of one-tenth volume of heated (56°C. for 2 hours) rabbit serum.  Varying amounts of 
a known dilution of penicillin  in broth (0.8, 0.72, 0.06, 0.48, 0.4, etc. in a total volume of 0.8 cc.) 
were inoculated with 10.4 of a 1 : 1,000 dilution of a 24 hour culture.  Results were read after 18 
hours in the incubator; and the end-point was usually sharply demarcated, a clear tube with 
no visible growth and no change in indicator color being followed by a turbid tube in which 
there had been an obvious production of acid. 
EXPERIMENTAL  RESULTS 
A.  Therapeutic  Activity  of P~icillins  F, G,  K,  and X  in Pneumococca~ and 
Streptococcal Infections in White Mice 
Pn~mococcd  Infections.--In  Table I  are  summarized the results of three 
experiments done at  different times.  Although  the  inoculum in those three 
>10  ~ 
experiments varied from a  low of  < 1@ ~.L.D. to a high of  > 104  <105  M.L.D., the 
results in the three experiments did not differ significantly,  and they have been 
combined in the table.  A single lot each of penicillin F, G, and X  was used 
throughout.  Two  lots  of  penicillin K  (Abbott)  were  used,  one  a  purified 
preparation, and one in which K  was said to constitute more than 90 per cent 
of  the  active  material,  but which  contained approximately 65  per  cent inert 
ingredients (cf.  above).  The  therapeutic  activity of  these  two preparations 
differed by Jess than 25 per cent, and they have been pooled in Table I. 
The total curative doses  (CDs0) of penicillins F, G, K, and X  were 4.6, 3.8, 
20,  and  2.4  mg.  per  kg.,  respectively.  These  figures  correspond  to  relative 
activities per milligram of 83,  100,  19, and 160, referred  to  G  as 100.  If  the 
comparison is made on the basis of "units" instead of milligrams, the relative ~Y  EAOLE  177 
therapeutic activities of F, G, K, and X  become 92, 100, 14, and 295, respec- 
tively.  However expressed, penicillin  X  was clearly the most active of the four 
peniciUins, K  was by far the least active, and F  and G  were essentially equal 
in  activity. 
TABLE I 
Tie Therapeutic  Activity of PeniczTlins  F, G, K, and X in Pneumococcal  Infections of White  Mice 
Mice weighing an average of 20 gin. (18 to 22 gm.) were inoculated intraperitoneally  with 
0.2 ec. of diluted 24 hour blood-broth culture of Type I pneumococci.  Intramuscular treat- 
ment with penicillin (0.2 cc. per injection) was begun 2 hours later and repeated every 3 hours 
for ten doses.  In three individual  experiments, the dilutions used for inoculation were 1 : 500, 
1:400, and 1:200, and these were found to contain 104, >10t  and >10~  < 10~'  < 10~ ~.r.n., respectively. 
Despite the variations in the size of the inoculum, the therapeutic  results did not vary sig- 
niticantly, and the three experiments have been pooled in the table. 
Total penicillin 
0.5 
1 
2 
4 
8 
16 
32 
CDso, rag. ,kg.* 
Therapeutic  activity,  relative  tc 
G as 100, 
per mg  ....................... 
per" unit"  ................... 
1120 
2/20 
6/20 
6/20 
15/20 
4.6 
83 
92 
Proportion of survivors  with penicillins 
G  K 
0/2O 
2/20 
3/20  0/6 
10/20  0/20 
17/20  5/20 
6/20 
18/20 
3.8  20 
100  19 
100  14 
1/2o 
1/2o 
9/20 
16/20 
19/20 
2.4 
160 
295 
* Calculated after method of Reed and Muench (12). 
>10  4 
Streptococcal  Infections.--Two experiments in which the inocula were 
<10  6 
>  105 
and  <  10  e ~.L.D. gave similar results, and have been combined in Table II.  1 
a In a third small scale experiment carried out at a later date, in which the inocnium was 
104 M.L.D., and in which the organisms were significantly less virulent,  judged by the time re- 
quired for death in the control animals, the curative doses of G, K, and X were consistently 
lower than in the first two experiments; but their relative activities referred to penicillin G as 
100 (100, 12.5, and 320) agreed satisfactorily with those shown in Table II.  The penicillin K 
used in this experiment was made by Pfizer, and was as inactive as the Abbott preparation 
used in the experiments of Table II. 178  "I'J:L~RAPEUTIC  ACTIVITY  OF  PENICILLINS  ~,  O,  K,  AND  X 
The total curative doses (CDs0) of peniclllins F, G, K, and  X  were 2.6,  1.3, 
14.0, and 0.5 mg. per kg.  These values correspond to relative activities of 50, 
100, 9, and 260, respectively, referred to G as 100.  If the penicillins are com- 
pared  on  the  basis  of units  rather  than  milligrams,  the  relative  therapeutic 
activities  of F,  G, K,  and X  become 54,  100,  7,  and  480.  Penicillin  X  was 
TABLE II 
The Therapeutic Activity of Penidllins F, G, K, and X in Streptococcal  Infections of White  Mice 
Mice weighing an average of 20 gin. (18 to 22 gm.) were inoculated intmperitoneally with 
0.2 cc. of a 1:20 dilution of an 18 hour blood-broth culture of Streptococcus pyogenes (C-203). 
Intramuscular treatment with penicillin was begun 2 hours later and repeated every 3 hours 
for 10 doses.  Two experiments with quantitatively similar results have been pooled in the 
table.  In one,  the inoculum  was found to represent > 10~  <10~ ~t.L,D., and in the other  <10~>106 
M.L.D. 
Total penicillin 
rag. per kg. 
0.25 
0.5 
1 
2 
4 
o/12 
2/12 
4/12 
9/12 
Proportion  of survivors with penicillins 
G  K* 
0/12 
6/12 
10/12  o/6 
10/12  0/12 
8 
16 
32 
CD~, rag. per kg.$ 
Activity relative to G as 100 
per mg  ....................... 
per"trait" ................... 
2.6 
50 
54 
0/12 
8/12 
9/12 
1.3  14.0 
100  9 
100  7 
X 
1/12 
6/12 
11/12 
5/6 
O/O 
0.5 
260 
480 
* Crystalline K (Abbott). 
:~ Calculated  after method of Reed and Muench  (12). 
again  the  most  active  of  the  four penicillins,  K  the  least  active  (1/29th as 
active as X  gravimetrically, and  1/68th as active as X  per unit), with F  and  G 
again intermediate  in activity. 
B.  Corrdations  between the  Relative Bactericidal  Activity of Penicillins F, G, 
K, and X  in Vitro, and Their Therapeutic Efficacy in Vivo 
If peniciUins F, G, K, and X  were identical in their pharmacological behavior, 
their  therapeutic  efficacy would  be  determined  solely by their  relative  bac- 
tericidal  activity  in v~tro.  However,  if one  compares  the  activities  of these HAm~Y EAGT.~'.  179 
penicillins against streptococci  (or pneumococci) in  vitro  with their curative 
doses against the same organism in vivo, it becomes apparent that there are 
consistent  and  significant  differences between  the  several  penicillins  with 
respect to that ratio. 
Experiments to determine the relative bactericidal activity of penicillins F, 
G, K, and X  are summarized in Table III.  The comparison of their in vitro 
activity with their therapeutic efficacy is given in Table IV. 
1.  As is there shown, the greatest discrepancy between bactericidal activity 
and therapeutic efficacy is observed with penicillin K.  In ~itro, penicillin K 
was 1.15 times more active than G against streptococci, and 2 times more active 
than G  against pneumococci.  Against the latter organism, it was the most 
TABLE III 
The Bactericidal Activities of PenicilUns F, G, K, and X  against Fneumococcu~ Type I  and 
Streptococcus pyogenes in Vitro 
(All values  have been expressed  relative to that of penicillin  G as 100.) 
Relative bactericidal activity in vltro versus 
Penicillin species  Pneumococcus Type I  51repto¢occus pyogenes (C-203) 
Individual experiments  Mean  Mean* 
F  50, 67, 56, 73  60  75 
G  100  100 
K  160, 160, 200, 160, 200, 200  180  115 
X  133, 121, 120, 160, 150  135  145 
* Averages of experiments reported in a previous communication (2) and others carried 
out subsequently. 
active of the four penicillins here studied.  In vivo, however, it was one-fifth 
as active as G against pneumococei, one-eleventh as active against streptococci, 
and in both cases, approximately one-tenth as effective as would be implied by 
its direct bactericidal activity in vitro. 
The therapeutic inactivity of penicillin K, first noted by Chesney (9)  and 
Mahoney and Arnold (10) in the treatment of experimental syphilis, is there- 
fore not peculiar to that disease, but is observed in any infection, and reflects 
the anomalous pharmacologic behavior of penicillin K.  This has been con- 
sidered in detail in the foregoing two papers of this series (5, 6).  Like peni- 
cillins F, G, and X, penicillin K  is inactivated by serum and plasma in vitro. 
Unlike those peniciUins, the rate of K inactivation accelerates as its concentra- 
tion is reduced; and at concentrations of less than 1 microgram per cc., an 
effectively bactericidal level for most organisms and  the  usual therapeutic 
range, it is inactivated so rapidly as to be of little value.  Because of a similar 
inactivation by blood and perhaps by the tissues in rico, it gives lower and more 180  THERAPEUTIC  ACTIVITY 017  PENICILLINS 17~  O~  K~ AND X 
evanescent blood curves than either F, G, or X.  Thus, after the intramuscular 
injection in rabbits of 0.6 mg. per kg., plasma levels of 0.1 microgram per cc. 
or more were sustained for 0.5 hours, as compared with 1.4 for G and 2.1 for X. 
In man, the corresponding values after intravenous injection were 0.5,  1, and 
1.3 hours.  For a  concentration of 0.1 microgram per cc., the disparity would 
be even greater.  Corresponding to its rapid inactivation by serum and plasma 
TABLE IV 
A  Comparison  between the Bactericidal  Activity of Penicillins F, G, K, and X  in  Vitro,  and 
Their Therapeu2ic E.~cacy in Vivo 
Penicillin 
species 
X 
Infecting  organism 
Streptococcus #yogenes  .  Pneumococcus  Type I 
Bacterici- 
dal action 
in vitro* 
F  75 
G  100 
K  115 
145 
Thera- 
peutic 
efficacy 
i~  tlvo* 
10O 
9 
26O 
Ratio§ of  Bactel  activity  ici- 
I~ vgvo  dal ac ion 
0.67  60 
1.0  100 
0.08  180 
1.71  135 
Thera- 
peutic 
efficacy 
83 
100 
19 
160 
Ratio§ of 
activi 
In ri~ 
1.4 
1.0 
0.1 
1.2 
Remarks 
The  activity  of peni- 
cillin  K  in  ~iro was 
approximately  one- 
tenth as great as that 
in ~itro 
The  therapeutic  activ- 
ity of penicillin X was 
greater  than  would 
be  implied  by  its 
bactericidal  activity 
in t~itr  o 
* Cf. Table III. 
Cf. Table II. 
§ All activities have been referred to that of penicillin G as 100. 
of in ~i2ro: in vivo activity for penicillin G was 1. 
[[ Cf. Table I. 
Of necessity, the ratio 
in vitro, and its rapid disappearance from the blood in vivo, the urinary recovery 
of active penicillin  in rabbits  averaged only 33 per cent for K, as compared 
with 61 for F, 87 for G, and 74 for X.  The corresponding recoveries in man 
were 28 per cent for K, as compared with 86 and 93 per cent, for G  and X, 
respectively. 
In summary, penicillin K  is rapidly inactivated by blood or plasma, and pre- 
sumably in consequence of a  similar inactivation  in  vivo  disappears  from the 
circulating  blood  far  more  rapidly  than  F,  G,  or X.  Corresponding  to  its 
rapid  inactivation,  the  therapeutic  efficacy of K  in  the  two  infections  here HA~RY  EAGLE  181 
studied averaged only one-tenth of its bactericidal activity against the same 
organisms in vitro. 
2.  In contrast to penicillin K, X was somewhat more effective therapeutically 
than one would have anticipated from its bactericidal action in vitro.  Against 
streptococci, X was 1.45 times more active than G/n vitro, but 2.6 times more 
active in vivo (Table II).  Against pneumococci, X was 1.35 times more active 
than G in vitro, but 1.6 times more active in  vivo.  In both infections, X was 
more active therapeutically than would be implied by its bactericidal activity 
in vitro. 
An adequate explanation is provided by the fact that, as shown in the pre- 
ceding paper ((6); cf. also references 3, 4, 7), penicillin X regularly gives higher 
and more sustained blood levels than does G in equal (gravimetric) dosage.  In 
rabbits,  intramuscular  injections  of 0.6  rag.  per kg.  provided  levels of 0.1 
microgram per cc. for 1.4 hours with G, and 2.1 hours with X.  In  man, the 
corresponding values were 1.6 and 2.3 hours, respectively.  The more sustained 
plasma levels probably reflect the fact (5) that penicillin X is inactivated more 
slowly by serum and plasma, and perhaps by the body tissues, than is;  e. g., 
penicillin  G. 
Although the foregoing differences seem slight,  they are of considerable prac- 
tical importance.  The proportion of surviving organisms after exposure to a 
given concentration of penicillin  for time t usually varies with the time as an 
exponential factor (8).  Even if one omits from consideration the somewhat 
higher average levels provided by X  as compared with G, a 1.5-fold difference 
in the time for which a given concentration is maintained may represent more 
than a two-fold difference in the number of organisms surviving. 
In summary, in the two infections here studied, penicillin  X was more effec- 
tive therapeutically than its bactericidal activity in vitro would imply, probably 
because it provides somewhat higher  and  more sustained  blood levels than 
penicillin  G administered in equal gravimetric dosage. 
C.  A  Comparison of the Relative Susceptibility  of Streptococci  and Pneumococci 
to Penicillin in Vitro and in Vivo 
One may assume as a  working hypothesis that  the therapeutic efficacy of 
penicillin  rests primarily on its direct bactericidal action, and that the defense 
mechanisms of the host contribute but little to that therapeutic action.  Under 
such circumstances.,  the widely varying curative dose of penicillin  in different 
infections could be determined largely by the similarly varying susceptibility 
of the particular organisms.  This is obviously an oversimplification,  and fails 
to take cognizance of such important factors as the varying number of organisms 
to be killed,  their possibly varying accessibility to penicillin,  and the rapidity 
and extent of the patient's immune response.  It is therefore of interest to note 
that in the experiments described in the present paper, the curative dose against 182  ~'H~:RAPEUTIC  ACTIVITY O1~  PENICILLINS  F~  G,  K~  AND  X 
a  given penicillin was in fact directly related to the varying susceptibility of 
those organisms in vitro. 
TABLE V 
The Corrdalion between the Susceptibility of Streplococci and Pneumococd to PenicilUn in Vitro, 
and the Cura~i~ Dose in Vi~o 
The factor under consideration is the relative susceptibility of different organisms to the 
same penicillin in vitro and in ~ivo.  In the table, as well as in Fig. 1, comparisons are to be 
made reading horizontally, and not vertically. 
mn 
el 
Streptococci 
Concentration of penicillin  which  Concentration  of penicillin 
inhibited  growth  which inhibited  growth 
in ~i~ro*  Curative  in ~itro 
doBe 
i~ e/wo  Individual  Mean  Individual  experiments  experimentl  Mean 
"r per e¢.  I  "~ ~r cc.  ~ per c¢.  ~ per ¢c. 
0.03 
0.03 
0.03 
0.03 
0.028 
mS. per ks. 
0.01  0.012 
0.012  0.013 
0.01  0.014 
0.012  0.012 
0.008  0.01 
0.012  0.011 
0.007  0.009 
0.009  0.015 
0.007 
0.009 
0.007 
0.007 
0.009 
0.009 
0.008 
0.008 
0.005 
0.005  0.007 
0.004  0.007 
0.005  0.005 
0.012  2.6 
0.01  1.3 
Pneemococci 
0.015  0.02 
0.02  0.02  0.019 
0.017  0.025 
0.011 
0.008  0.01  0.008  14  0.01  20  0.013  0.013 
0.008 
Curative 
dole 
in eieo 
ms. #or kS. 
4.6 
3.8 
0.02  0.017 
0.005-0.006  0.5  0.015  0.012  0.016  2.4 
0.013  0.017 
* Under the conditions of the in ~itro assay technic here used. 
Conclusion:  The greater resistance of pneumococcl  to penicillin in  vitro  was  regularly 
reflected in a higher curative dose in ~/~o. 
This is shown in Table V  and Fig. 1.  The average minimum concentration 
of  (e.g.)  penicillin G  which inhibited the growth of streptococci and pneumo- 
cocci in vitro under the conditions of the assay method here used was 0.01 and 
0.019 microgram  per cc., respectively.  Corresponding  to this twofold differ- 
ence in the susceptibility of the organisms in vitro,  the curative doses of G  in 
the two infections were 1.3 and 3.8 rag. per kg.  With penicillin X, a  threefold 
difference  in  the  inhibiting  concentration  for  streptococci  and pneumococci ~A~Y  EAOLE  183 
in vitro (0.005 and 0.016 microgram per cc.) was reflected in a fivefold difference 
in the curative dose (0.5 and 2.4 rag. per kg.); and a  similar paraUelism was 
noted with penicillin F  (inhibitory concentrations of 0.012 and 0.03 microgram 
per cc., and curative doses of 2.6 and 4.6 rag. per kg.).  Penicillin K is not con- 
sidered in Fig.  1 because  of  the  complication  introduced  by its  rapid inac- 
tivation in vi¢o. 
$tropto-  Pne.mo- 
003 ,-  6  coccus  coccus 
¢.t 
(102  -  4 
2- 
~,  • 
•  °-0  -  0 
E 
¢; 
i0 
I_  rl, 
[']:Effective  Concentration 
in  Vitro, u/cc 
~:Curative  Dose in  Vivo. 
mykg. 
FIo.  1. The correlation between the susceptibility of streptococci and pneumococci to 
penicillin  gn vitro and the curative dose in ¢/¢o (after data of Table V). 
The implication is clear that the curative dose of penicillin in a given infection 
is in Large part determined by the susceptibility of the particular organism to 
peniciUin in vitro.  It must nevertheless be emphasized that in the two experi- 
mental infections here studied, the host species, the method of inoculation, and 
the schedule of administration were identical throughout; the type of infection 
was  similar  (a massive fulminating septicemia), and comparable numbers of 
organisms had to be killed in order to effect cure (inocula of the same order 
of magnitude,  10' to 10  e ~.T..D., were used in all the experiments).  Although 184  THERAPEUTIC  ACTIVITY  O]~ PENICILLINS  F, G, K~ AND  X 
the activity of penicillin in these controlled experimental  infections paralleled 
its activity in vitro, wide differences in the inoculum or in the age of the infec- 
tion would probably be reflected in a  correspondingly varying curative dose; 
and if the organisms were at areas not readily accessible to penicillin, or if the 
immune response were of a different order of magnitude in time or extent, the 
susceptibility of the organism to penicillin might no longer be the factor which 
solely or even primarily determined the curative dose. 
DISCUSSION 
The data of the present and preceding papers indicate that in suitably con- 
trolled experiments  the therapeutic  activity of a  given penicillin  species in a 
given infection is materially affected by two factors: the intrinsic bactericidal 
action  of the penicillin  against  the particular  organism,  as measured  by its 
activity in vitro,  and  the  pharmacological  behavior of the penicillin  in  vivo, 
measured by the height and amplitude of the blood penicillin curve. 
Of  the  four  natural  penicillins  so far  identified,  X  is  the  penicillin  of 
choice in  the  treatment  of streptococcal and pneumococcal infections.  Not 
only is it intrinsically  more active against  these organisms  than  F  or G  ((2); 
page 179); but in addition,  milligram for milligram,  penicillin X  yields higher 
and more sustained blood levels than those penicillins (5, 3, 4, 7)).  In conse- 
quence, the curative dose of X  in milligrams has been here found to be four- 
tenths that of G in streptococcal infections, and two-thirds that of G in pneu- 
mococcal infections.  Compared on the basis of units rather than milligrams, 
X  was therapeutically  three  times as active as G  against  pneumococci,  and 
five times as active against streptococci.  Against gonococci also, X  has been 
found to be the most active of the four natural penicillins in vitro (II), and more 
effective than G in the treatment of the human disease (3). 
In  vitro,  penicillin  K  has perhaps  the  highest  over-all activity of all four 
penicillins,  being the most active against  staphylococci (I) and pneumococci 
(page 179), and the second most active against streptococci (2) and spirochetes 
(2).  In vivo, however, it had only a minor therapeutic activity in two of these 
infections, due to the fact that it is rapidly inactivated in vivo, and  provides 
significant blood levels for relatively short periods.  The therapeutic inactivity 
of K  thus has  a  pharmacological  basis, is observed in every infection  so far 
studied, and removes that penicillin from serious consideration as a therapeutic 
agent  for  systemic  administration.  It  may perhaps  be  of value  in  topical 
application,  if it is present in sufficient concentration  (the rate of inactivation 
varies inversely with its concentration), and particularly if exudates are found 
to be less active than is serum in its inactivation. 
The  commercial production  of penicillin  has already gone through  several 
stages.  At  the  present  writing,  the  trend  is  to  the  production  of a  highly 
refined and perhaps crystalline product, consisting almost entirely of penicillin ~.l~x  EACZ.S  185 
G.  This has certain definite advantages.  It permits  the administration  of 
penicillin  on a gravimetric basis, as a drug, instead of on an arbitrary scale of 
staphylococcidal units w~aich has no necessary m~aning  in  other  infections. 
Equally important, penicillin  G is the major single penicillin  component pro- 
duced by the presently available strains of mold.  The proportion of G relative 
to the other penicillins  can be further increased by the addition of suitable 
precursor substances to the nutrient medium, and it is formed in the deep tank 
cultures which facilitate large scale production. 
It must nevertheless be emphasized that in many infections,  penicillin  G is 
not the penicillin  of choice.  Of the three natural penicillins  which are to be 
considered,  F, G, and X, penicillin  G is known to be distinctly inferior to X 
in the treatment of at least three infections (streptococcal, pneumococcal, and 
gonococcal).  If the difference between G or X were solely quantitative, this 
would be of only minor importance.  Thus, if it required 120,000 units of G 
as compared to 25,000 units of X  to cure a case of gonorrhea, or if it required 
800,000 units of G instead of 200,000 units of X  to cure a case of pneumonia, 
the problem would simply be one of adequate dosage.  There is, however, a 
real possibility that the difference may be qualitative as well as quantitative. 
It may well be that of 100 cases of subacute bacterial endocarditis, perhaps 
only e.g. 70 can be cured with G, no matter in what dosage it is employed, while 
perhaps  90 could be cured with X.  This  qualitative  difference  cannot  be 
studied in animals, for in the experimental infections susceptible to penicillin, 
all the animals (> 95 per cent) are cured if adequate doses are administered. 
It can, however, be studied in man,  given an adequate supply of  the  pure 
penicillins. 
The fact that such wide differences  in bactericidal activity and  pharmaco- 
logical behavior have been demonstrated among the first four natural penicRlius 
to be identified suggests that additional penicillins may yet be discovered which 
are more active against specific organisms,  or have more favorable pharmaco- 
logical properties, than any of those now available. 
SuMMARy 
1.  The relative bactericidal activities of penicillins  F, G, K, and X  against 
Type I pneumococcus in dtro were 60, 100, 180, and 135.  The corresponding 
activities against Streptococcus  pyogenes, strain C-203, were 75, 100, 115, and 
145, respectively. 
2.  The total curative doses (CDs0) of penicillins  F, G, K, and X in pneumo- 
coccal infections of white mice (ten injections at 3 hour intervals)  were 4.6, 
3.8,  20, and 2.4 mg. per kg., respectively, or relative activities of 83, 100, 19, 
and 160, referred to G as 100. 
3.  The corresponding curative doses in streptococcal infections of white mice 
were 2.6,  1.3, 14.0, and 0.5  mg.  per kg.,  or relative activities of 50,  100, 9, 
and  260. 186  THERAPEUTIC ACTIVITY  OF  PENICILLINS  ~  G,  K,  AND  X 
4.  Penicillin K  was therefore one-tenth as active in ~vo as would be implied 
by its bactericidal activity in vitro.  This probably reflects its rapid inactiva- 
tion in vivo, evidenced by the low and evanescent blood levels observed in both 
rabbits and  man,  and  the  low urinary  recovery of this  species of penicillin. 
5.  Penicillin X was significantly more active therapeutically than its bacteri- 
cidal activity in vitro would imply.  This probably reflects its slower inactiva- 
tion in rico, evidenced by the somewhat higher and more prolonged blood levels 
afforded by this penicillin  in  comparison  with penicillin  G.  judged  by the 
mouse infections with  the  strains  here used, penicillin  X  is the penicillin  of 
choice in the treatment of infections with pneumococcus Type I and hemolytic 
streptococci. 
6.  The curative dose of penicillin  in streptococcal and pneumococcal infec- 
tions  paralleled  the  varying  susceptibility  of  these  organisms  to  penicillin 
in vitro. 
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